(NYSE: CHE) Chemed's forecast annual revenue growth rate of 3.82% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.91%.
Chemed's revenue in 2025 is $2,530,634,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2025 to be $36,458,637,930, with the lowest CHE revenue forecast at $35,325,502,330, and the highest CHE revenue forecast at $37,988,370,990. On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $38,923,207,860, with the lowest CHE revenue forecast at $37,039,369,925, and the highest CHE revenue forecast at $40,962,851,940.
In 2027, CHE is forecast to generate $40,311,298,970 in revenue, with the lowest revenue forecast at $39,121,506,590 and the highest revenue forecast at $41,911,853,005.